Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:106799rdf:typepubmed:Citationlld:pubmed
pubmed-article:106799lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:106799lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:106799lifeskim:mentionsumls-concept:C0025887lld:lifeskim
pubmed-article:106799lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:106799lifeskim:mentionsumls-concept:C1561577lld:lifeskim
pubmed-article:106799lifeskim:mentionsumls-concept:C1514811lld:lifeskim
pubmed-article:106799lifeskim:mentionsumls-concept:C1706462lld:lifeskim
pubmed-article:106799pubmed:issue12lld:pubmed
pubmed-article:106799pubmed:dateCreated1979-5-24lld:pubmed
pubmed-article:106799pubmed:abstractTextThe electrophysiological properties of Mexiletine were investigated by endocavitary His Bundle recording and programmed electrical stimulation of the heart in 30 patients. Differing dosage (2, 2.7 and 3.4 mg/kg) were given intravenously in 3 groups of 10 patients. The effects on the length of the sinus cycle, conduction intervals and cardiac refractory periods were observed and the following results obtained : 1. Sinus rhythm increased at all dosages but this effect was much more pronounced with 3.4 mg/kg dosage (--12.8% +/- 2.81% : : % shortening of sinus cycle with respect to the basal cycle +/- SD, p less than 0.005); 2. Atrioventricular nodal conduction time (A-H interval) decreased, the effect being more marked with the larger dose regimes; 3.His-Pirkinje conduction time (H-V interval) unaltered except in 3 cases where it increased by 5 ms after injection of 2.7 mg/kg; 4. Relative refractory period of His-Parkinje system shortened, this effect also being more pronounced with the larger doses ( --3.75 +/- 0.25% :2.7 mg/kg, p less than 0,001; -- 7 +/- 1.46% 3.4 mg/kg, p less than 0.005). In conclusion, the changes observed in the His-Purkinje system after mexiletine were similar to those of Lignocaine and Diphenylhydantoin. The drug also appears to have a marked vagal inhibitory effect as shown by the acceleration of the sinus rhythm and reduced atrioventricular conduction times.lld:pubmed
pubmed-article:106799pubmed:languagefrelld:pubmed
pubmed-article:106799pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:106799pubmed:citationSubsetIMlld:pubmed
pubmed-article:106799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:106799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:106799pubmed:statusMEDLINElld:pubmed
pubmed-article:106799pubmed:monthDeclld:pubmed
pubmed-article:106799pubmed:issn0003-9683lld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:AlexandreJ...lld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:DelahayeJ PJPlld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:TouboulPPlld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:ChatelainM...lld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:GressardAAlld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:AtallahGGlld:pubmed
pubmed-article:106799pubmed:authorpubmed-author:MichelonGGlld:pubmed
pubmed-article:106799pubmed:issnTypePrintlld:pubmed
pubmed-article:106799pubmed:volume71lld:pubmed
pubmed-article:106799pubmed:ownerNLMlld:pubmed
pubmed-article:106799pubmed:authorsCompleteYlld:pubmed
pubmed-article:106799pubmed:pagination1429-37lld:pubmed
pubmed-article:106799pubmed:dateRevised2009-2-13lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-H...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-E...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-A...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-P...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-F...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-M...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-A...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-H...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-B...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-M...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-S...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-D...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-P...lld:pubmed
pubmed-article:106799pubmed:meshHeadingpubmed-meshheading:106799-M...lld:pubmed
pubmed-article:106799pubmed:year1978lld:pubmed
pubmed-article:106799pubmed:articleTitle[Electrophysiological study on mexiletine in man with reference to dose-response relation].lld:pubmed
pubmed-article:106799pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:106799pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:106799lld:pubmed